<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04242563</url>
  </required_header>
  <id_info>
    <org_study_id>38RC19.116</org_study_id>
    <nct_id>NCT04242563</nct_id>
  </id_info>
  <brief_title>Virtual Reality for Preoperative Anxiety in Interventional Cardiology</brief_title>
  <acronym>No PANIC</acronym>
  <official_title>Virtual Reality for Preoperative Anxiety in Interventional Cardiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Improving the management of perioperative anxiety is important. Anxiety can have an impact on&#xD;
      the intervention and can increase postoperative complications as well as emotional and&#xD;
      behavioral incidents that then have an impact on adherence to care. These findings are also&#xD;
      true in interventional cardiology. That is why, for several months, the Grenoble University&#xD;
      hospital paramedical team, in collaboration with the medical profession, improved by using&#xD;
      several techniques (educational sheet, therapeutic communication). Following a survey of the&#xD;
      patients of Grenoble university hospital, a gray area persists in their care. The room where&#xD;
      the patient attends his examination. The investigators would then use the new technology that&#xD;
      makes virtual reality in the transfer room to evaluate its benefit in a random study on&#xD;
      preoperative anxiety in interventional cardiology.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2, 2020</start_date>
  <completion_date type="Anticipated">April 3, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 3, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of virutal reality on the management of preoperative anxiety measured by heart rate variability in interventional cardiology room in patient awaiting coronarography</measure>
    <time_frame>Time 1 : 60 minutes</time_frame>
    <description>Heart rate variability during 20 minutes by a heart rate monitor in transfer room</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of anxiety level in patient awaiting coronarography</measure>
    <time_frame>TIme 1 : 60 minutes, Time 2 : 120 minutes</time_frame>
    <description>The Analogical Self-Assessment Scale for Preoperative Anxiety (0 - no anxiety to 10 - uncontrollable anxiety)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction on the global care in the coronary angiography room</measure>
    <time_frame>Time 3 : 180 minutes</time_frame>
    <description>Patient satisfaction questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of virtual reality on coronarography intervention duration</measure>
    <time_frame>Time 2 : 120 minutes</time_frame>
    <description>Intervention duration (in minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of virtual reality on coronarography irradiation dose</measure>
    <time_frame>Time 2 : 120 minutes</time_frame>
    <description>Irradiation dose (in Gy.cm²)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of virtual reality on coronarography scopy time</measure>
    <time_frame>Time 2 : 120 minutes</time_frame>
    <description>scopy time (in minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of virtual reality on administration of analgesic and anxiolytic drug peri and per coronarography procedure</measure>
    <time_frame>Time 2 : 120 minutes</time_frame>
    <description>administration of analgesic and anxiolytic drug peri and perprocedure (drug name and dose)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of virtual reality on rate and success of coronarography procedure</measure>
    <time_frame>Time 2 : 120 minutes</time_frame>
    <description>number and success of PCI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">156</enrollment>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>CONTROL GROUP</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No virtual reality</description>
  </arm_group>
  <arm_group>
    <arm_group_label>INTERVENTION GROUP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient equipped with Virtual reality in transfer room.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VIRTUAL REALITY</intervention_name>
    <description>Patient equipped with virtual reality in transfer room</description>
    <arm_group_label>INTERVENTION GROUP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Major male or female patient&#xD;
&#xD;
          -  Coronarography procedure programmed for exploration of coronary artery disease&#xD;
             following a positive ischemia test, realized in ambulatory&#xD;
&#xD;
          -  Patient who has given written consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Arrhythmia patient and / or patient with a pacemaker&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  Patient who has already had coronarography&#xD;
&#xD;
          -  Prior revascularization by coronary bypass&#xD;
&#xD;
          -  End-stage renal disease (Creatinine clearance &lt;30 ml / min),&#xD;
&#xD;
          -  Allergy to iodine contrast agent&#xD;
&#xD;
          -  Blind or visually impaired patient (high degree)&#xD;
&#xD;
          -  Deaf or hard of hearing patient&#xD;
&#xD;
          -  Patient with claustrophobia or unable to wear a mask over the eyes&#xD;
&#xD;
          -  Patient whose physical or psychological state could compromise obtaining informed&#xD;
             consent and compliance with protocol requirements&#xD;
&#xD;
          -  Patient under administrative or judicial supervision&#xD;
&#xD;
          -  Foreign patient who does not understand French&#xD;
&#xD;
          -  Major patient protected by law (article L1121-8 and L1121-5)&#xD;
&#xD;
          -  Pregnant or lactating patient&#xD;
&#xD;
          -  Patient not affiliated with social security&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Verane Cabassut</last_name>
    <phone>0476763640</phone>
    <email>vcabassut@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clémence Charlon</last_name>
    <phone>0476766652</phone>
    <email>ccharlon@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anais Adolle</last_name>
      <phone>0476766813</phone>
      <email>aadolle@chu-grenoble.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>December 30, 2019</study_first_submitted>
  <study_first_submitted_qc>January 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>interventional cardiopathy</keyword>
  <keyword>preoperative anxiety</keyword>
  <keyword>virtual reality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

